Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Nebraska
University of California, Irvine
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Bristol-Myers Squibb
Novartis
Vanderbilt-Ingram Cancer Center
Masonic Cancer Center, University of Minnesota
Montefiore Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Thomas Jefferson University
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Takeda
National Cancer Institute (NCI)
Sanofi
OncoVerity, Inc.
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
PrECOG, LLC.
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
Memorial Sloan Kettering Cancer Center
Novartis
Aprea Therapeutics
Fred Hutchinson Cancer Center
Syros Pharmaceuticals
University of Pittsburgh
University of Florida
Fred Hutchinson Cancer Center
Syros Pharmaceuticals
Washington University School of Medicine